Producing nature's gene-chips: the generation of peptides for display by MHC class I molecules.

Gene-chips contain thousands of nucleotide sequences that allow simultaneous analysis of the complex mixture of RNAs transcribed in cells. Like these gene-chips, major histocompatibility complex (MHC) class I molecules display a large array of peptides on the cell surface for probing by the CD8(+) T cell repertoire. The peptide mixture represents fragments of most, if not all, intracellular proteins. The antigen processing machinery accomplishes the daunting task of sampling these proteins and cleaving them into the precise set of peptides displayed by MHC I molecules. It has long been believed that antigenic peptides arose as by-products of normal protein turnover. Recent evidence, however, suggests that the primary source of peptides is newly synthesized proteins that arise from conventional as well as cryptic translational reading frames. It is increasingly clear that for many peptides the C-terminus is generated in the cytoplasm, and N-terminal trimming occurs in the endoplasmic reticulum in an MHC I-dependent manner. Nature's gene-chips are thus both parsimonious and elegant.

[1]  N. Shastri,et al.  Alloreactive CD8+ T cells can recognize unusual, rare, and unique processed peptide/MHC complexes. , 1996, Journal of immunology.

[2]  A. Vitiello,et al.  Impaired immunoproteasome assembly and immune responses in PA28-/- mice. , 1999, Science.

[3]  A. Goldberg,et al.  Interferon-γ Can Stimulate Post-proteasomal Trimming of the N Terminus of an Antigenic Peptide by Inducing Leucine Aminopeptidase* , 1998, The Journal of Biological Chemistry.

[4]  M. Feltkamp,et al.  Major differences in transporter associated with antigen presentation (TAP)-dependent translocation of MHC class I-presentable peptides and the effect of flanking sequences. , 1995, Journal of immunology.

[5]  N. Shastri,et al.  Generation of naturally processed peptide/MHC class I complexes is independent of the stability of endogenously synthesized precursors. , 1996, Journal of immunology.

[6]  R. Henderson,et al.  HLA-A2.1-associated peptides from a mutant cell line: a second pathway of antigen presentation. , 1992, Science.

[7]  L. Eisenlohr,et al.  Murine Transporter Associated with Antigen Presentation (TAP) Preferences Influence Class I–restricted T Cell Responses , 1997, The Journal of experimental medicine.

[8]  F. Triebel,et al.  A non-AUG-defined alternative open reading frame of the intestinal carboxyl esterase mRNA generates an epitope recognized by renal cell carcinoma-reactive tumor-infiltrating lymphocytes in situ. , 1999, Journal of immunology.

[9]  A. Agulnik,et al.  The HLA-A*0201-restricted H-Y antigen contains a posttranslationally modified cysteine that significantly affects T cell recognition. , 1997, Immunity.

[10]  D. R. Madden,et al.  The structure of HLA-B27 reveals nonamer self-peptides bound in an extended conformation , 1991, Nature.

[11]  R. Kridel,et al.  Frame of the Human Macrophage Colony-stimulating Factor Gene Is Independently Translated and Codes for an Antigenic Peptide of 14 Amino Acids Recognized by Tumor-infiltrating CD 8 T Lymphocytes , 2001 .

[12]  H. Ploegh,et al.  Generation, translocation, and presentation of MHC class I-restricted peptides. , 1995, Annual review of biochemistry.

[13]  A Sette,et al.  The peptide-binding motif for the human transporter associated with antigen processing , 1995, The Journal of experimental medicine.

[14]  A. Goldberg,et al.  Two distinct proteolytic processes in the generation of a major histocompatibility complex class I-presented peptide. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[15]  H. Rammensee,et al.  Uneven tissue distribution of minor histocompatibility proteins versus peptides is caused by MHC expression , 1991, Cell.

[16]  R. Henderson,et al.  Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry. , 1992, Science.

[17]  Forest M. White,et al.  Phosphorylated Peptides Are Naturally Processed and Presented by Major Histocompatibility Complex Class I Molecules in Vivo , 2000, The Journal of experimental medicine.

[18]  Hans-Georg Rammensee,et al.  MHC Ligands and Peptide Motifs , 1998, Molecular Biology Intelligence Unit.

[19]  J. Yewdell,et al.  MHC class I-associated peptides produced from endogenous gene products with vastly different efficiencies. , 1997, Journal of immunology.

[20]  J. Yewdell,et al.  The generation of MHC class I-associated peptides is only partially inhibited by proteasome inhibitors: involvement of nonproteasomal cytosolic proteases in antigen processing? , 1997, Journal of immunology.

[21]  S. Rosenberg,et al.  The intronic region of an incompletely spliced gp100 gene transcript encodes an epitope recognized by melanoma-reactive tumor-infiltrating lymphocytes. , 1997, Journal of immunology.

[22]  Edward J. Collins,et al.  Three-dimensional structure of a peptide extending from one end of a class I MHC binding site , 1994, Nature.

[23]  Hans-Georg Rammensee,et al.  Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells , 1990, Nature.

[24]  P. Schrier,et al.  Interleukin‐2‐induced, melanoma‐specific T cells recognize camel, an unexpected translation product of LAGE‐1 , 1999, International journal of cancer.

[25]  N. Shastri,et al.  LacZ inducible, antigen/MHC-specific T cell hybrids. , 1994, International immunology.

[26]  N. Shastri,et al.  The role of MHC class I molecules in the generation of endogenous peptide/MHC complexes. , 1995, Journal of immunology.

[27]  A. Diehl,et al.  Impaired immune responses and altered peptide repertoire in tapasin-deficient mice , 2000, Nature Immunology.

[28]  J. Shabanowitz,et al.  An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins , 1996, The Journal of experimental medicine.

[29]  C. Watts,et al.  Antigen Traffic Pathways in Dendritic Cells , 2000, Traffic.

[30]  N. Shastri,et al.  Presentation of out-of-frame peptide/MHC class I complexes by a novel translation initiation mechanism. , 1999, Immunity.

[31]  P. Kloetzel,et al.  Ubiquitin and proteasomes: Antigen processing by the proteasome , 2001, Nature Reviews Molecular Cell Biology.

[32]  Jonathan W. Yewdell,et al.  Rapid degradation of a large fraction of newly synthesized proteins by proteasomes , 2000, Nature.

[33]  U. Koszinowski,et al.  Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighboring residues in the protein , 1991, Cell.

[34]  M. Bogyo,et al.  A proteolytic system that compensates for loss of proteasome function , 1998, Nature.

[35]  R. Henderson,et al.  Direct identification of an endogenous peptide recognized by multiple HLA-A2.1-specific cytotoxic T cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[36]  Stefan Imreh,et al.  Inhibition of antigen processing by the internal repeat region of the Epstein–Barr virus nuclear antigen-1 , 1995, Nature.

[37]  A. Varshavsky,et al.  The N-end rule: functions, mysteries, uses. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[38]  P. Parham,et al.  Overlap in the repertoires of peptides bound in vivo by a group of related class I HLA-B allotypes , 1995, Current Biology.

[39]  E. Gilboa,et al.  A frameshift mutation at the NH2 terminus of the nucleoprotein gene does not affect generation of cytotoxic T lymphocyte epitopes. , 1991, Journal of immunology.

[40]  P. Cresswell,et al.  How selective is the transporter associated with antigen processing? , 1996, Immunity.

[41]  C. Figdor,et al.  A Human Minor Histocompatibility Antigen Specific for B Cell Acute Lymphoblastic Leukemia , 1999, The Journal of experimental medicine.

[42]  J. Neefjes,et al.  The major substrates for TAP in vivo are derived from newly synthesized proteins , 2000, Nature.

[43]  T. Elliott,et al.  Processing of major histocompatibility class I-restricted antigens in the endoplasmic reticulum , 1995, The Journal of experimental medicine.

[44]  J. Shabanowitz,et al.  Proteasomes can either generate or destroy MHC class I epitopes: evidence for nonproteasomal epitope generation in the cytosol. , 1998, Journal of immunology.

[45]  A. Goldberg,et al.  Rate of antigen degradation by the ubiquitin-proteasome pathway influences MHC class I presentation. , 1995, Journal of immunology.

[46]  Maria L. Wei,et al.  HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides , 1992, Nature.

[47]  J. Monaco,et al.  The genetics of proteasomes and antigen processing. , 1995, Annual review of genetics.

[48]  H. Rammensee,et al.  Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules , 1991, Nature.

[49]  N. Shastri,et al.  Measurement of ligand-induced activation in single viable T cells using the lacZ reporter gene. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[50]  H. Ljunggren,et al.  Association of class I major histocompatibility heavy and light chains induced by viral peptides , 1989, Nature.

[51]  B. Coupar,et al.  Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen , 1988, The Journal of experimental medicine.

[52]  J. Yewdell,et al.  Trimming of antigenic peptides in an early secretory compartment , 1994, The Journal of experimental medicine.

[53]  R. Siliciano,et al.  Transporter-independent processing of HIV-1 envelope protein for recognition by CD8+ T cells , 1993, Nature.

[54]  K. F. Lindahl,et al.  Identification of the rat maternally transmitted minor histocompatibility antigen. , 1997, Journal of immunology.

[55]  N. Shastri,et al.  Specific proteolytic cleavages limit the diversity of the pool of peptides available to MHC class I molecules in living cells. , 1999, Journal of immunology.

[56]  L. Frappier,et al.  Human CD8+ T cell responses to EBV EBNA1: HLA class I presentation of the (Gly-Ala)-containing protein requires exogenous processing. , 1997, Immunity.

[57]  C. Farina,et al.  Translation of a Retained Intron in Tyrosinase-related Protein (TRP) 2 mRNA Generates a New Cytotoxic T Lymphocyte (CTL)-defined and Shared Human Melanoma Antigen Not Expressed in Normal Cells of the Melanocytic Lineage , 1998, The Journal of experimental medicine.

[58]  H. Rammensee,et al.  Identification of classical minor histocompatibility antigen as cell-derived peptide , 1990, Nature.

[59]  M. Bevan,et al.  Introduction of soluble protein into the class I pathway of antigen processing and presentation , 1988, Cell.

[60]  L. Kaer,et al.  Tapasin: an ER chaperone that controls MHC class I assembly with peptide. , 2001, Trends in immunology.

[61]  Hans-Georg Rammensee,et al.  Coordinated Dual Cleavages Induced by the Proteasome Regulator PA28 Lead to Dominant MHC Ligands , 1996, Cell.

[62]  D. Madden The three-dimensional structure of peptide-MHC complexes. , 1995, Annual review of immunology.

[63]  J. Shabanowitz,et al.  Differences in the Expression of Human Class I MHC Alleles and Their Associated Peptides in the Presence of Proteasome Inhibitors1 , 2001, The Journal of Immunology.

[64]  N. Shastri,et al.  Presentation without Proteolytic Cleavage of Endogenous Precursors in the MHC Class I Antigen Processing Pathway (*) , 1995, The Journal of Biological Chemistry.

[65]  H. Yamana,et al.  A Gene Encoding Antigenic Peptides of Human Squamous Cell Carcinoma Recognized by Cytotoxic T Lymphocytes , 1998, The Journal of experimental medicine.

[66]  J. Yewdell,et al.  Mechanisms of exogenous antigen presentation by MHC class I molecules in vitro and in vivo: implications for generating CD8+ T cell responses to infectious agents, tumors, transplants, and vaccines. , 1999, Advances in immunology.

[67]  J. Yewdell,et al.  Introduction of a Glycosylation Site into a Secreted Protein Provides Evidence for an Alternative Antigen Processing Pathway: Transport of Precursors of Major Histocompatability Complex Class I–Restricted Peptides from the Endoplasmic Reticulum to the Cytosol , 1997, The Journal of experimental medicine.

[68]  S. Tonegawa,et al.  Altered peptidase and viral-specific T cell response in LMP2 mutant mice. , 1994, Immunity.

[69]  A. Goldberg,et al.  26S proteasomes and immunoproteasomes produce mainly N‐extended versions of an antigenic peptide , 2001, The EMBO journal.

[70]  P. Coulie,et al.  A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[71]  K. Rock,et al.  Generation of class I MHC-restricted T-T hybridomas. , 1990, Journal of immunology.

[72]  Eric O Long,et al.  Presentation of a cytosolic antigen by major histocompatibility complex class II molecules requires a long-lived form of the antigen. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[73]  S. Tonegawa,et al.  TAP1 mutant mice are deficient in antigen presentation, surface class I molecules, and CD4−8+ T cells , 1992, Cell.

[74]  S. Riddell,et al.  Cytomegalovirus selectively blocks antigen processing and presentation of its immediate–early gene product , 1996, Nature.

[75]  P. Srivastava,et al.  An Endoplasmic Reticulum Protein Implicated in Chaperoning Peptides to Major Histocompatibility of Class I Is an Aminopeptidase* , 2001, The Journal of Biological Chemistry.

[76]  K Eichmann,et al.  The specificity of proteasomes: impact on MHC class I processing and presentation of antigens , 1999, Immunological reviews.

[77]  J. Yewdell,et al.  Expression of a membrane protease enhances presentation of endogenous antigens to MHC class I-restricted T lymphocytes , 1992, Cell.

[78]  M. Lotze,et al.  Identification of T-cell epitopes: rapid isolation of class I-presented peptides from viable cells by mild acid elution. , 1993, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.

[79]  T. Braciale,et al.  Presentation of viral antigen to class I major histocompatibility complex-restricted cytotoxic T lymphocyte. Recognition of an immunodominant influenza hemagglutinin site by cytotoxic T lymphocyte is independent of the position of the site in the hemagglutinin translation product , 1991, The Journal of experimental medicine.

[80]  F. Chisari,et al.  Human Transporters Associated with Antigen Processing (Taps) Select Epitope Precursor Peptides for Processing in the Endoplasmic Reticulum and Presentation to T Cells , 1999, The Journal of experimental medicine.

[81]  D. Jackson,et al.  Coupled Transcription and Translation Within Nuclei of Mammalian Cells , 2001, Science.

[82]  W. Green,et al.  An alternative translational reading frame encodes an immunodominant retroviral CTL determinant expressed by an immunodeficiency-causing retrovirus. , 1998, Journal of immunology.

[83]  A. Goldberg,et al.  Degradation of cell proteins and the generation of MHC class I-presented peptides. , 1999, Annual review of immunology.

[84]  E. Pamer,et al.  The Listeria monocytogenes-secreted p60 Protein Is an N-end Rule Substrate in the Cytosol of Infected Cells , 1997, The Journal of Biological Chemistry.

[85]  P. Paz,et al.  Discrete proteolytic intermediates in the MHC class I antigen processing pathway and MHC I-dependent peptide trimming in the ER. , 1999, Immunity.

[86]  T. Boon,et al.  T cell-recognized antigenic peptides derived from the cellular genome are not protein degradation products but can be generated directly by transcription and translation of short subgenic regions. A hypothesis , 2004, Immunogenetics.

[87]  Hans-Georg Rammensee,et al.  Cellular peptide composition governed by major histocompatibility complex class I molecules , 1990, Nature.

[88]  N. Shastri,et al.  A rare cryptic translation product is presented by Kb major histocompatibility complex class I molecule to alloreactive T cells , 1995, The Journal of experimental medicine.

[89]  S. Rosenberg,et al.  Utilization of an alternative open reading frame of a normal gene in generating a novel human cancer antigen , 1996, The Journal of experimental medicine.

[90]  W. Baumeister,et al.  A giant protease with potential to substitute for some functions of the proteasome. , 1999, Science.

[91]  Hans-Georg Rammensee,et al.  Two new proteases in the MHC class I processing pathway , 2000, Nature Immunology.

[92]  N. Shastri,et al.  Endogenous generation and presentation of the ovalbumin peptide/Kb complex to T cells. , 1993, Journal of immunology.

[93]  A. Goldberg,et al.  Distinct proteolytic processes generate the C and N termini of MHC class I-binding peptides. , 1999, Journal of immunology.

[94]  P. Cresswell,et al.  The nature of the MHC class I peptide loading complex , 1999, Immunological reviews.

[95]  J. Yewdell,et al.  Defective ribosomal products (DRiPs): a major source of antigenic peptides for MHC class I molecules? , 1996, Journal of immunology.

[96]  S. Rosenberg,et al.  A breast and melanoma-shared tumor antigen: T cell responses to antigenic peptides translated from different open reading frames. , 1998, Journal of immunology.

[97]  A. Goldberg,et al.  Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules , 1994, Cell.

[98]  T. Elliott,et al.  Naturally processed peptides , 1990, Nature.

[99]  L. Eisenlohr,et al.  Initiation Codon Scanthrough versus Termination Codon Readthrough Demonstrates Strong Potential for Major Histocompatibility Complex Class I–restricted Cryptic Epitope Expression , 1997, The Journal of experimental medicine.

[100]  H. Eisen,et al.  Evidence that a single peptide-MHC complex on a target cell can elicit a cytolytic T cell response. , 1996, Immunity.

[101]  T. Yasuda,et al.  Identification of a unique antigen peptide pRL1 on BALB/c RL male 1 leukemia recognized by cytotoxic T lymphocytes and its relation to the Akt oncogene , 1994, The Journal of experimental medicine.

[102]  L. Eisenlohr,et al.  Ribosomal scanning past the primary initiation codon as a mechanism for expression of CTL epitopes encoded in alternative reading frames , 1996, The Journal of experimental medicine.

[103]  E. Pamer,et al.  Precise prediction of a dominant class I MHC-restricted epitope of Listeria monocytogenes , 1991, Nature.

[104]  R. Henderson,et al.  Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. , 1994, Science.

[105]  J. Monaco,et al.  Structural and serological similarity of MHC-linked LMP and proteasome (multicatalytic proteinase) complexes , 1991, Nature.

[106]  R. Binder,et al.  Heat Shock Protein-chaperoned Peptides but Not Free Peptides Introduced into the Cytosol Are Presented Efficiently by Major Histocompatibility Complex I Molecules* , 2001, The Journal of Biological Chemistry.

[107]  P. A. Peterson,et al.  Crystal structures of two viral peptides in complex with murine MHC class I H-2Kb. , 1994, Science.

[108]  J. Pipas,et al.  8 – Cytotoxic T Cell Recognition of the SV40 Tumor Antigen: A Note of Caution , 1988 .

[109]  C. Melief,et al.  The rat cim effect: TAP allele-dependent changes in a class I MHC anchor motif and evidence against C-terminal trimming of peptides in the ER. , 1996, Immunity.

[110]  J. Yewdell,et al.  Direct delivery of exogenous MHC class I molecule-binding oligopeptides to the endoplasmic reticulum of viable cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[111]  H. Rammensee,et al.  Characterization of naturally occurring minor histocompatibility peptides including H-4 and H-Y. , 1990, Science.

[112]  T. Elliott,et al.  Recognition of out‐of‐frame major histocompatibility complex class I‐restricted epitopes in vivo , 1996, European journal of immunology.

[113]  P. Srivastava,et al.  Heat shock proteins come of age: primitive functions acquire new roles in an adaptive world. , 1998, Immunity.

[114]  P. Paz,et al.  Reading within the lines: naturally processed peptides displayed by MHC class I molecules. , 1998, Current opinion in immunology.

[115]  K. Rajewsky,et al.  MHC class I expression in mice lacking the proteasome subunit LMP-7. , 1994, Science.

[116]  P. Chomez,et al.  Genes coding for T-cell-defined tum transplantation antigens: point mutations, antigenic peptides, and subgenic expression. , 1989, Cold Spring Harbor symposia on quantitative biology.

[117]  N. Bhardwaj,et al.  Dendritic cells resurrect antigens from dead cells. , 2001, Trends in immunology.

[118]  F. Koning,et al.  Isolation of an immunodominant viral peptide that is endogenously bound to the stress protein GP96/GRP94. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[119]  S. Nathenson,et al.  Isolation of an endogenously processed immunodominant viral peptide from the class I H–2Kb molecule , 1990, Nature.

[120]  H. Yonekawa,et al.  Maternally transmitted histocompatibility antigen of mice: A hydrophobic peptide of a mitochondrially encoded protein , 1990, Cell.

[121]  J. Yewdell,et al.  Two Novel Routes of Transporter Associated with Antigen Processing (TAP)-independent Major Histocompatibility Complex Class I Antigen Processing , 1997, The Journal of experimental medicine.

[122]  R. Siliciano,et al.  An epitope-selective, transporter associated with antigen presentation (TAP)-1/2-independent pathway and a more general TAP-1/2-dependent antigen-processing pathway allow recognition of the HIV-1 envelope glycoprotein by CD8+ CTL. , 1995, Journal of immunology.

[123]  L. Kaer,et al.  Impaired assembly yet normal trafficking of MHC class I molecules in Tapasin mutant mice. , 2000, Immunity.

[124]  N. Shastri,et al.  ER aminopeptidases generate a unique pool of peptides for MHC class I molecules , 2001, Nature Immunology.

[125]  P. Endert Genes regulating MHC class I processing of antigen , 1999 .

[126]  P M Kloetzel,et al.  A single residue exchange within a viral CTL epitope alters proteasome-mediated degradation resulting in lack of antigen presentation. , 1996, Immunity.

[127]  D. Wiley,et al.  T Cell Receptor–MHC Interactions up Close , 2001, Cell.

[128]  N. Brouwenstijn,et al.  MHC class I molecules can direct proteolytic cleavage of antigenic precursors in the endoplasmic reticulum. , 2001, Immunity.

[129]  N. Shastri,et al.  Major Histocompatibility Class I Molecules Can Present Cryptic Translation Products to T-cells (*) , 1995, The Journal of Biological Chemistry.

[130]  P. Paz,et al.  Minors held by majors: the H13 minor histocompatibility locus defined as a peptide/MHC class I complex. , 1997, Immunity.

[131]  J. Yewdell,et al.  Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody. , 1997, Immunity.

[132]  Ira Mellman,et al.  Dendritic Cells Specialized and Regulated Antigen Processing Machines , 2001, Cell.

[133]  G W Butcher,et al.  Two different, highly exposed, bulged structures for an unusually long peptide bound to rat MHC class I RT1-Aa. , 2001, Immunity.

[134]  F. Brasseur,et al.  A peptide recognized by human cytolytic T lymphocytes on HLA-A2 melanomas is encoded by an intron sequence of the N- acetylglucosaminyltransferase V gene , 1996, The Journal of experimental medicine.